Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A ▿ Paul A. Aeed † , Casey L. Young ‡ , Marek M. Nagiec § and Åke P. Elhammer * Pharmacia Corp., 7000 Portage Rd., Kalamazoo, Michigan 49001 ABSTRACT By using a detergent-washed membrane preparation, the interaction of the fungal natural product inhibitor aureobasidin A (AbA) with inositol phosphorylceramide synthase (IPC synthase) was studied by kinetic analysis of wild-type and mutant enzyme-catalyzed reactions. AbA inhibited the wild-type enzyme from both Candida albicans and Saccharomyces cerevisiae in an irreversible, time-dependent manner, with apparent K i values of 183 and 234 pM, respectively. Three synthetic chemistry-derived AbA derivatives, PHA-533179, PHA-556655, and PHA-556656, had affinities 4 to 5 orders of magnitude lower and were reversible inhibitors that competed with the donor substrate phosphatidylinositol (PI). AbA was a reversible, apparently noncompetitive inhibitor, with a K i of 1.4 μM, of the IPC synthase from an AbA-resistant S. cerevisiae mutant. The K m values for both substrates (ceramide and PI) were similar when they interacted with the mutant and the wild-type enzymes. By contrast, the V max for the mutant enzyme was less than 10% of that for the wild-type enzyme. A comparison of the results obtained with AbA with those obtained with two other natural products inhibitors, rustmicin and khafrefungin, revealed that while rustmicin appeared to be a reversible, noncompetitive inhibitor of the wild-type enzyme, with a K i of 16.0 nM, khafrefungin had the kinetic properties of a time-dependent inhibitor and an apparent K i of 0.43 nM. An evaluation of the efficiencies of these compounds as inhibitors of the mutant enzyme revealed for both a drop in the apparent affinity for the enzyme of more than 2 orders of magnitude. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Antimicrobial Agents and Chemotherapy American Society For Microbiology

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A

Antimicrobial Agents and Chemotherapy , Volume 53 (2): 496 – Feb 1, 2009

Abstract

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A ▿ Paul A. Aeed † , Casey L. Young ‡ , Marek M. Nagiec § and Åke P. Elhammer * Pharmacia Corp., 7000 Portage Rd., Kalamazoo, Michigan 49001 ABSTRACT By using a detergent-washed membrane preparation, the interaction of the fungal natural product inhibitor aureobasidin A (AbA) with inositol phosphorylceramide synthase (IPC synthase) was studied by kinetic analysis of wild-type and mutant enzyme-catalyzed reactions. AbA inhibited the wild-type enzyme from both Candida albicans and Saccharomyces cerevisiae in an irreversible, time-dependent manner, with apparent K i values of 183 and 234 pM, respectively. Three synthetic chemistry-derived AbA derivatives, PHA-533179, PHA-556655, and PHA-556656, had affinities 4 to 5 orders of magnitude lower and were reversible inhibitors that competed with the donor substrate phosphatidylinositol (PI). AbA was a reversible, apparently noncompetitive inhibitor, with a K i of 1.4 μM, of the IPC synthase from an AbA-resistant S. cerevisiae mutant. The K m values for both substrates (ceramide and PI) were similar when they interacted with the mutant and the wild-type enzymes. By contrast, the V max for the mutant enzyme was less than 10% of that for the wild-type enzyme. A comparison of the results obtained with AbA with those obtained with two other natural products inhibitors, rustmicin and khafrefungin, revealed that while rustmicin appeared to be a reversible, noncompetitive inhibitor of the wild-type enzyme, with a K i of 16.0 nM, khafrefungin had the kinetic properties of a time-dependent inhibitor and an apparent K i of 0.43 nM. An evaluation of the efficiencies of these compounds as inhibitors of the mutant enzyme revealed for both a drop in the apparent affinity for the enzyme of more than 2 orders of magnitude.

Loading next page...
 
/lp/american-society-for-microbiology/inhibition-of-inositol-phosphorylceramide-synthase-by-the-cyclic-S6JmuQAr2u

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Society For Microbiology
Copyright
Copyright © 2009 by the American society for Microbiology.
ISSN
0066-4804
eISSN
1098-6596
DOI
10.1128/AAC.00633-08
pmid
19047657
Publisher site
See Article on Publisher Site

Abstract

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A ▿ Paul A. Aeed † , Casey L. Young ‡ , Marek M. Nagiec § and Åke P. Elhammer * Pharmacia Corp., 7000 Portage Rd., Kalamazoo, Michigan 49001 ABSTRACT By using a detergent-washed membrane preparation, the interaction of the fungal natural product inhibitor aureobasidin A (AbA) with inositol phosphorylceramide synthase (IPC synthase) was studied by kinetic analysis of wild-type and mutant enzyme-catalyzed reactions. AbA inhibited the wild-type enzyme from both Candida albicans and Saccharomyces cerevisiae in an irreversible, time-dependent manner, with apparent K i values of 183 and 234 pM, respectively. Three synthetic chemistry-derived AbA derivatives, PHA-533179, PHA-556655, and PHA-556656, had affinities 4 to 5 orders of magnitude lower and were reversible inhibitors that competed with the donor substrate phosphatidylinositol (PI). AbA was a reversible, apparently noncompetitive inhibitor, with a K i of 1.4 μM, of the IPC synthase from an AbA-resistant S. cerevisiae mutant. The K m values for both substrates (ceramide and PI) were similar when they interacted with the mutant and the wild-type enzymes. By contrast, the V max for the mutant enzyme was less than 10% of that for the wild-type enzyme. A comparison of the results obtained with AbA with those obtained with two other natural products inhibitors, rustmicin and khafrefungin, revealed that while rustmicin appeared to be a reversible, noncompetitive inhibitor of the wild-type enzyme, with a K i of 16.0 nM, khafrefungin had the kinetic properties of a time-dependent inhibitor and an apparent K i of 0.43 nM. An evaluation of the efficiencies of these compounds as inhibitors of the mutant enzyme revealed for both a drop in the apparent affinity for the enzyme of more than 2 orders of magnitude.

Journal

Antimicrobial Agents and ChemotherapyAmerican Society For Microbiology

Published: Feb 1, 2009

There are no references for this article.